Stocks and Investing Stocks and Investing
Fri, May 19, 2023
Thu, May 18, 2023

Andrew Fein Reiterated (TCRX) at Strong Buy and Held Target at $15 on, May 18th, 2023


Published on 2024-10-28 03:53:12 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "TScan Therapeutics, Inc." (TCRX) at Strong Buy and Held Target at $15 on, May 18th, 2023.

Andrew, nor any peers, have made any analyst calls on TCRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources